Post-void residual (PVR) volume and urinary retention assessments in a randomized, double-blind, Phase IIIb trial of mirabegron add-on treatment in incontinent overactive bladder (OAB) patients with an inadequate response to 4-week solifenacin monotherapy (BESIDE)
NEUROUROLOGY AND URODYNAMICS（2016）
关键词
incontinent overactive bladder,urinary retention assessments,mirabegron,post-void,double-blind
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要